KALA BIO, Inc. (KALA)
NASDAQ·Healthcare·Biotechnology
$2.55
+3.24%
Mkt Cap $5.69M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$1.50
Range $1.50 – $1.50
Implied Upside
-41.2%
Consensus $1.50 vs current $2.55
NASDAQ·Healthcare·Biotechnology
$2.55
+3.24%
Mkt Cap $5.69M
No recent rating data.
Price Target (5 analysts)
$1.50
Range $1.50 – $1.50
-41.2%
Consensus $1.50 vs current $2.55